The average MedImmune Director of Investor Relations earns an estimated $198,662 annually. MedImmune's Director of Investor Relations compensation is $56,132 more than the US average for a Director of Investor Relations.
Last updated 7 years ago.
The majority of Directors of Investor Relations at MedImmune believe they're compensated fairly. 100% of Directors of Investor Relations at MedImmune say they receive annual bonuses, and the vast majority (100%) are satisfied with their benefits. See more compensation ratings at MedImmune